NAV

MK-0731

Identification

Generic Name
MK-0731
DrugBank Accession Number
DB08037
Background

MK-0731 is a kinesin spindle protein inhibitor and antineoplastic agent.

Type
Small Molecule
Groups
Experimental
Structure
3D
Similar Structures
Weight
Average: 459.5039
Monoisotopic: 459.21336177
Chemical Formula
C25H28F3N3O2
Synonyms
Not Available
External IDs
  • MK 0731
  • MK-0731
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UKinesin-like protein KIF11Not AvailableHumans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as phenylpyrrolines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrroline ring through a CC or CN bond.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Pyrrolines
Sub Class
Phenylpyrrolines
Direct Parent
Phenylpyrrolines
Alternative Parents
Pyrroline carboxylic acids and derivatives / Fluorobenzenes / Piperidines / Aryl fluorides / Pyrroles / Ureas / Trialkylamines / Azacyclic compounds / Primary alcohols / Organopnictogen compounds
show 5 more
Substituents
2-phenylpyrroline / Alcohol / Alkyl fluoride / Alkyl halide / Amine / Aromatic heteromonocyclic compound / Aryl fluoride / Aryl halide / Azacycle / Benzenoid
show 21 more
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
8HIJ5G3O02
CAS number
845256-65-7
InChI Key
MYBGWENAVMIGMM-GIFXNVAJSA-N
InChI
InChI=1S/C25H28F3N3O2/c1-29-11-10-23(22(28)15-29)30(2)24(33)31-14-17(20-12-19(26)8-9-21(20)27)13-25(31,16-32)18-6-4-3-5-7-18/h3-9,12-13,22-23,32H,10-11,14-16H2,1-2H3/t22-,23+,25-/m1/s1
IUPAC Name
(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide
SMILES
CN([C@H]1CCN(C)C[C@H]1F)C(=O)N1CC(=C[C@@]1(CO)C1=CC=CC=C1)C1=C(F)C=CC(F)=C1

References

General References
Not Available
PubChem Compound
11655511
PubChem Substance
99444508
ChemSpider
9830249
BindingDB
50252149
ChEMBL
CHEMBL481931
ZINC
ZINC000014209414
PDBe Ligand
K30
PDB Entries
3cjo

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedTreatmentCancer1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0802 mg/mLALOGPS
logP3.4ALOGPS
logP2.93Chemaxon
logS-3.8ALOGPS
pKa (Strongest Acidic)14.61Chemaxon
pKa (Strongest Basic)6.98Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area47.02 Å2Chemaxon
Rotatable Bond Count4Chemaxon
Refractivity121.21 m3·mol-1Chemaxon
Polarizability46.29 Å3Chemaxon
Number of Rings4Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9952
Blood Brain Barrier+0.9176
Caco-2 permeable-0.5557
P-glycoprotein substrateSubstrate0.7901
P-glycoprotein inhibitor IInhibitor0.7805
P-glycoprotein inhibitor IIInhibitor0.8687
Renal organic cation transporterNon-inhibitor0.5527
CYP450 2C9 substrateNon-substrate0.7023
CYP450 2D6 substrateNon-substrate0.7757
CYP450 3A4 substrateSubstrate0.6695
CYP450 1A2 substrateNon-inhibitor0.7911
CYP450 2C9 inhibitorNon-inhibitor0.7632
CYP450 2D6 inhibitorNon-inhibitor0.7716
CYP450 2C19 inhibitorNon-inhibitor0.7688
CYP450 3A4 inhibitorNon-inhibitor0.784
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7013
Ames testNon AMES toxic0.6953
CarcinogenicityNon-carcinogens0.8784
BiodegradationNot ready biodegradable0.9867
Rat acute toxicity2.7689 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.7763
hERG inhibition (predictor II)Inhibitor0.8401
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-03di-0020900000-f9ca05bfa568488d9488
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-0000900000-bfb7ee970f7ffe8f8be8
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0ap0-0282900000-35756b925b340ad32396
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-03dl-0110900000-b21ab5a2f750b5642f1e
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-02mj-2590100000-02a1df674e086ec1cb5f
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-00li-0292200000-4ed655627c5582d30926
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-202.83197
predicted
DeepCCS 1.0 (2019)
[M+H]+204.8036
predicted
DeepCCS 1.0 (2019)
[M+Na]+210.71614
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Details1. Kinesin-like protein KIF11
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Protein kinase binding
Specific Function
Motor protein required for establishing a bipolar spindle. Blocking of KIF11 prevents centrosome migration and arrest cells in mitosis with monoastral microtubule arrays.
Gene Name
KIF11
Uniprot ID
P52732
Uniprot Name
Kinesin-like protein KIF11
Molecular Weight
119158.025 Da
References
  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at September 15, 2010 21:27 / Updated at June 12, 2020 16:52